Purdue's OxyContin Patent Suit Survives Dismissal Bid
A New York federal judge refused Friday to throw out a patent suit Purdue Pharma LP brought against KVK-Tech Inc. over plans to market a generic version of painkiller OxyContin, ruling...To view the full article, register now.
Already a subscriber? Click here to view full article